115 related articles for article (PubMed ID: 3602022)
1. Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses.
Antignani PL; Todini AR; Saliceti F; Pacino G; Bartolo M
Pharmatherapeutica; 1987; 5(1):50-6. PubMed ID: 3602022
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
Schweiger H; Ortmeier CJ
Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
[TBL] [Abstract][Full Text] [Related]
4. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline--a new drug for the treatment of intermittent claudication.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
8. [Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
Vogralik VG; Vogralik MV; Runov GP; Runova AA; Kostrov AI
Klin Med (Mosk); 1982 Oct; 60(10):90-4. PubMed ID: 7176484
[No Abstract] [Full Text] [Related]
9. [Sudden deafness: apropos of 19 cases. Results of treatment with pentoxifylline. Value of erythrocyte filtration time].
Denis F; Ketari M; Benzaken J; Renou G
Ann Otolaryngol Chir Cervicofac; 1989; 106(1):21-6. PubMed ID: 2719437
[TBL] [Abstract][Full Text] [Related]
10. [Use of erythrocyte filtration in the study of diabetic vasculopathy. Therapeutic efficacy of pentoxifylline].
Moratti F; Cortiana M; Taglioretti D
Clin Ter; 1983 Jul; 106(1):19-25. PubMed ID: 6627879
[No Abstract] [Full Text] [Related]
11. The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration.
Parnetti L; Ciuffetti G; Mercuri M; Lupattelli G; Senin U
Pharmatherapeutica; 1986; 4(10):617-27. PubMed ID: 3602014
[TBL] [Abstract][Full Text] [Related]
12. [Erythrocyte filterability and treatment with pentoxifylline].
Valentini M; Sciannameo F; Francucci M; Tockner M; Sassano L; Allegra A
Ric Clin Lab; 1983; 13 Suppl 3():455-8. PubMed ID: 6673029
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
14. Combined intravenous and oral pentoxifylline in the treatment of peripheral vascular disease. A clinical trial.
Thomson GJ; Thomson S; Todd AS; Vohra RK; Carr MH; Walker MG
Int Angiol; 1990; 9(4):266-70. PubMed ID: 2099961
[TBL] [Abstract][Full Text] [Related]
15. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
Chyzy R; Lukjan H; Rość D; Bielawiec M; Sawicka J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):549-54. PubMed ID: 2446996
[TBL] [Abstract][Full Text] [Related]
16. [Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups].
Solerte SB; Adamo S; Viola C; Zambianchi E; Ferrari E
Ric Clin Lab; 1985; 15 Suppl 1():515-26. PubMed ID: 4035232
[TBL] [Abstract][Full Text] [Related]
17. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
Regenthal R; Voigt H; Reuter W; Preiss R
Z Gesamte Inn Med; 1991 Apr; 46(6):185-90. PubMed ID: 2063598
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
Angelkort B; Doppelfeld E
Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
[TBL] [Abstract][Full Text] [Related]
19. [Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
Beykirch H; Reuter W; Voigt H; Herrmann W
Z Gesamte Inn Med; 1989 Feb; 44(3):77-9. PubMed ID: 2728555
[TBL] [Abstract][Full Text] [Related]
20. [Fibrinogen and pentoxifylline. Results of a French cooperative exploratory study of stage II arteritis].
Soria J; Lancrenon S; Chassoux G
J Mal Vasc; 1989; 14 Suppl A():29-34. PubMed ID: 2715734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
